SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

tilator, the only ones who know is IPCI

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Samsa Member Profile
 
Followed By 8
Posts 1,129
Boards Moderated 0
Alias Born 06/30/16
160x600 placeholder
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 10/20/2017 5:20:34 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 10/18/2017 3:20:22 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/16/2017 6:03:43 AM
Intellipharmaceutics Announces Closing of US$4 Million Financing "GlobeNewswire Inc." - 10/13/2017 5:45:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/13/2017 6:04:15 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/12/2017 4:07:48 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/11/2017 8:07:45 AM
Intellipharmaceutics Announces US$4 Million Registered Direct Offering "GlobeNewswire Inc." - 10/11/2017 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/10/2017 5:25:56 PM
Intellipharmaceutics Announces Third Quarter 2017 Results "GlobeNewswire Inc." - 10/10/2017 5:20:59 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/25/2017 7:12:00 AM
Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista™ NDA "GlobeNewswire Inc." - 9/25/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/20/2017 5:18:47 PM
Intellipharmaceutics Announces Receipt of Nasdaq Notice "GlobeNewswire Inc." - 9/20/2017 5:10:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/5/2017 2:43:50 PM
Intellipharmaceutics Provides Operational Update "GlobeNewswire Inc." - 9/5/2017 2:35:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/1/2017 8:10:22 AM
Intellipharmaceutics Appoints New Chief Financial Officer "GlobeNewswire Inc." - 9/1/2017 8:00:00 AM
Monteverde & Associates PC Invites IntelliPharmaCeutics International Inc. Shareholders with Losses in Excess of $1... "PR Newswire (US)" - 8/15/2017 4:52:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/8/2017 3:06:36 PM
Intellipharmaceutics Announces Resignation of Chief Financial Officer "GlobeNewswire Inc." - 8/8/2017 3:00:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/31/2017 8:10:21 AM
Intellipharmaceutics Intends to Vigorously Defend Recently Filed Purported Class Action Lawsuit "GlobeNewswire Inc." - 7/31/2017 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/27/2017 6:07:34 AM
Intellipharmaceutics Provides Update on FDA Advisory Committees Meeting for Rexista™ (oxycodone hydrochloride extended rele... "GlobeNewswire Inc." - 7/26/2017 8:15:00 PM
Samsa   Friday, 11/10/17 01:59:22 PM
Re: tilator post# 31195
Post # of 31332 
tilator, the only ones who know is IPCI and they aren't talking. my guess, they probably received some communication from the FDA but no clue where it stands. lets face it, there is a reason 6 of the companies ANDA's are years old waiting on approvals. The FDA isnt that backed up any longer.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist